Check-Cap Ltd.

CHEK | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.86

+$0.03 (+1.64%)

At close: May 21, 2026, 09:30 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+1.64%

(1D)

No price chart data available for 1D timeframe.

Rating

Updated: Sep 24, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $10.88M

1D Range

1.77 1.86

52W Range

0.56 3.13

Valuation (TTM)

PE -0.43

PB -7.51

EV/EBITDA -1.16

Valuation (NTM)

Forward PE 0.30

Forward PEG 0.09

Price Target N/A

Cash Flow

FCF Yield -0.1%

SBC Adj. FCF Yield -0.1%

SBC Impact -0.1%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y -150.0% | 0.0%

Dil EPS 3Y | 5Y -12.4% | 33.0%

FCF 3Y | 5Y 79.4% | 20.3%

Returns

ROA -6670.8%

ROE -226.2%

ROIC 1974.8%

Financial Health

Net Cash

$265K

Current Ratio 0.15

Interest Coverage -2,883.22

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Check-Cap Ltd. is an Israeli medical diagnostics company currently in the clinical development phase. It is dedicated to advancing a novel capsule-based screening method that employs ultra-low-dose X-...

Sector Healthcare

Industry Medical - Diagnostics & Research

Employees 85

IPO Date Mar 4, 2015

Website www.check-cap.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.